Role of MexA-MexB-OprM efflux pump system in chronic pseudomonas aeruginosa pulmonary infection in mice

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 32, Issue 4, 2012, Pages 546-551

  Gong, Fengyun ^a   Zhan, Weili ^a   Wang, Lili ^b   Song, Ying ^a   Xing, Mingyou ^a   Song, Jianxin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b QINGDAO CENTRAL HOSPITAL   (China)

Author keywords

Antibacterial resistance; MexA MexB OprM efflux pump; MexB; Pseudomonas aeruginosa; Pulmonary infections

Indexed keywords

CARRIER PROTEIN; MEXA PROTEIN, PSEUDOMONAS AERUGINOSA; MEXB PROTEIN, PSEUDOMONAS AERUGINOSA; OPRM PROTEIN, PSEUDOMONAS AERUGINOSA; OUTER MEMBRANE PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; LUNG; METABOLISM; MICROBIOLOGY; MOUSE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; LUNG; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84865652092     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-012-0094-7     Document Type: Article

References (23)

1. Majumdar S, Kirby A, Berry N, et al. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit. J Hosp Infect, 2004,58(2):160-161
2. Higgins PG, Fluit AC, Milatovic D, et al. Antimicrobial susceptibility of imipenem-resistant Pseudomonas aerugi nosa. Antimicrob Agents Chemother, 2002,50(2): 299-301
3. Mesaros N, Nordmann P, Roussel-Delvallez M, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect, 2007,13(6):560-578
4. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. Antimicrob Chemother, 2001,47(3):247-250
5. Aeschlimann Jr. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gram-negative bacteria. Pharmacotherapy, 2003,23 (7):916-924
6. Kriengkauykiat J, Porter E, Lomovskaya O, et al. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother, 2005,49(2):565-570
7. Kukavica-Ibrulj I, Bragozi A, Paroni M, et al. In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J Bacteriol, 2008,190(8): 2804-2813
8. Maria MD, Borrell N, Perez JL, et al. Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the E test and disk diffusion. Antimicrob Agents Chemother, 2004,48(7):2665-2672
9. Wang Y, Cela E, Gagnon S, et al. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Respir Res, 2010,30(11):166
10. Araki N, Yanagihara K, Morinaga Y, et al. In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model. J Infect Chemother, 2011,17(3):318-321
11. Song Z, Kharazmi A, Wu H, et al. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Clin Diagn Lab Immunol, 1998,5(6):882-887
12. Jin X, Lin Z, Xie X, et al. The delayed response of Toll-like receptors may relate to Pseudomonas aeruginosa keratitis exacerbating rapidly at the early stages of infection. J Clin Microbiol Infect Dis, 2010,29(2):231-238
13. Deng JC, Cheng G, Newstead MW, et al. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Inv, 2006,116(9):2532-2542
14. Strateva T, Yordanov D. Pseudomonas aeruginosa-a phenomenon of bacterial resistance. Med Microbiol, 2009,58(Pt9):1133-1148
15. Li XZ, Nikaido H, Poole K, et al. Role of MexA-MexBOprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother, 1995,39(9):1948-1953
16. Vojtová V, Kolár M, Uvízl R, et al. Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units. New Microbiol, 2011,34(3):291-298
17. Li XZ, Barré.N, Poole K, et al. Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexFOprN multidrug efflux systems in Pseudomonas aeruginosa. J Antimicrob Chemother, 2000,46(6):885-893
18. Wagner JG, Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev, 2000,52(3):349-374
19. Reiniger N, Lee MM, Coleman FT, et al. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun, 2007,75(4): 1598-1608
20. Wu H, Song Z, Givskov M, et al. Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology, 2001,147(Pt 5):1105-1113
21. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res, 2004,23(1):1-30
22. Ni M, Zhang D, Qi J, et al. Analysis of AmpC beta-lactamase gene in Pseudomonas aeruginosa. J Huazhong Univ Sci Technol Med Sci, 2005,25(1)17-19
23. Cheng X, Wang P, Wang Y, et al. Identification and distribution of the clinical isolates of imipenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lacta mase and/or class 1 integron genes. J Huazhong Univ Sci Technol Med Sci, 2008,28(3):235-238